These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 8739293)
21. VISCERAL LEISHMANIASIS FROM AN AREA PREVIOUSLY NOT KNOWN TO BE ENDEMIC; DANGUR, BENSHANGUL-GUMUZ, REGIONAL STATE, NORTHWEST ETHIOPIA: A CASE REPORT. Abera A; Tasew G; Degu A; Almneh M; Mulugeta A; Aseffa A; Gadisa E Ethiop Med J; 2016 Jan; 54(1):33-6. PubMed ID: 27191028 [TBL] [Abstract][Full Text] [Related]
22. Immunoblot analysis of the humoral immune response to Leishmania donovani polypeptides in cases of human visceral leishmaniasis: its usefulness in prognosis. Kumar P; Pai K; Tripathi K; Pandey HP; Sundar S Clin Diagn Lab Immunol; 2002 Sep; 9(5):1119-23. PubMed ID: 12204969 [TBL] [Abstract][Full Text] [Related]
23. [Visceral leishmaniasis (Kala-Azar) in a 3-year-old German infant (author's transl)]. Wittermann C; Bienzle U; Betke K Klin Padiatr; 1979 May; 191(3):311-7. PubMed ID: 222940 [TBL] [Abstract][Full Text] [Related]
24. Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India. Verma SK; Ahmad S; Shirazi N; Kusum A; Kaushik RM; Barthwal SP Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):730-2. PubMed ID: 17382981 [TBL] [Abstract][Full Text] [Related]
25. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar. Das VN; Ranjan A; Bimal S; Siddique NA; Pandey K; Kumar N; Verma N; Singh VP; Sinha PK; Bhattacharya SK Natl Med J India; 2005; 18(3):131-3. PubMed ID: 16130613 [TBL] [Abstract][Full Text] [Related]
26. Case report: Acute renal injury as a result of liposomal amphotericin B treatment in sodium stibogluconate unresponsive visceral leishmaniasis. Zhao S; Zhang D; Li L; Mao Q Am J Trop Med Hyg; 2011 Dec; 85(6):1035-7. PubMed ID: 22144439 [TBL] [Abstract][Full Text] [Related]
27. Acute erythroid toxicity in visceral leishmaniasis: a rare complication of antimonial therapy. Sharma S; Malhan P; Pujani M; Rath B Indian J Pathol Microbiol; 2008; 51(4):546-7. PubMed ID: 19008592 [TBL] [Abstract][Full Text] [Related]
28. A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal. Karki P; Koirala S; Parija SC; Hansdak SG; Das ML Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):154-8. PubMed ID: 9740292 [TBL] [Abstract][Full Text] [Related]
29. Visceral leishmaniasis (Kala-Azar) in transplant recipients: case report and review. Berenguer J; Gómez-Campderá F; Padilla B; Rodríguez-Ferrero M; Anaya F; Moreno S; Valderrábano F Transplantation; 1998 May; 65(10):1401-4. PubMed ID: 9625028 [TBL] [Abstract][Full Text] [Related]
30. Epidemiologic, clinical, diagnostic and therapeutic aspects of visceral leishmaniasis in renal transplant recipients: experience from thirty cases. de Silva AA; Pacheco e Silva Filho Á; Sesso Rde C; Esmeraldo Rde M; de Oliveira CM; Fernandes PF; de Oliveira RA; de Silva LS; de Carvalho VP; Costa CH; Andrade JX; da Silva DM; Chaves RV BMC Infect Dis; 2015 Feb; 15():96. PubMed ID: 25877483 [TBL] [Abstract][Full Text] [Related]
32. [Visceral leishmaniasis. Personal observation and review of epidemiology, clinical aspects and therapy]. Dickerhoff R; Müller A; Bode U Klin Padiatr; 1990; 202(5):347-51. PubMed ID: 2170739 [TBL] [Abstract][Full Text] [Related]
33. Pancytopenia in a simultaneous pancreas and kidney transplant recipient: an unexpected cause - a case of visceral leishmaniasis in a transplant recipient. Aardema H; Sijpkens YW; Visser LG Clin Nephrol; 2009 Apr; 71(4):460-2. PubMed ID: 19356384 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic and management problems in childhood visceral leishmaniasis in south-western Saudi Arabia. Benjamin B; Annobil SH; Bassuni WA Ann Trop Paediatr; 1994; 14(1):7-13. PubMed ID: 7516138 [TBL] [Abstract][Full Text] [Related]
35. Treatment of visceral leishmaniasis using sodium stibogluconate in a dose of 15 mg antimony/kg body weight twice daily for 30 days: a preliminary report. Chunge CN; Gachihi G; Mugambi M; Chulay JD; Spencer HC East Afr Med J; 1984 Jul; 61(7):570-4. PubMed ID: 6100588 [No Abstract] [Full Text] [Related]
36. Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine. Sundar S; Kumar K; Chakravarty J; Agrawal D; Agrawal S; Chhabra A; Singh V Trans R Soc Trop Med Hyg; 2006 Jul; 100(7):698-700. PubMed ID: 16325873 [TBL] [Abstract][Full Text] [Related]
37. [Big spleen, big problems]. Boon DA; De Nef JJ; Kager PA Tijdschr Kindergeneeskd; 1985 Dec; 53(6):224-7. PubMed ID: 3006280 [TBL] [Abstract][Full Text] [Related]
38. [Visceral leishmaniasis (kala-azar) in acquired immunodeficiency syndrome (AIDS)]. Just G; Simader R; Helm EB; Stille W; Falk S; Stutte HJ; Hübner K Dtsch Med Wochenschr; 1988 Dec; 113(49):1920-2. PubMed ID: 2848675 [TBL] [Abstract][Full Text] [Related]
39. Co-administration of glycyrrhizic acid with the antileishmanial drug sodium antimony gluconate (SAG) cures SAG-resistant visceral leishmaniasis. Bhattacharjee A; Majumder S; Majumdar SB; Choudhuri SK; Roy S; Majumdar S Int J Antimicrob Agents; 2015 Mar; 45(3):268-77. PubMed ID: 25600891 [TBL] [Abstract][Full Text] [Related]
40. The irreplaceable image: Acute toxicity in erythroid bone marrow progenitors after antimonial therapy. Hernández JA; Navarro JT; Force L Haematologica; 2001 Dec; 86(12):1319. PubMed ID: 11726328 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]